"Core cash expenses showed a small reduction year on year, despite increases in Bacchus Marsh plant activity and India project preparation works. Increased sales of by-products from the consolidated entities R&D activities in addition to the provision of consulting services resulted in a year-on-year increase in sales revenue of $71k." - looks lke we are on track to proving Matmor for Indiaand a cheeky $71k in the kitty
Ann: Full Year Statutory Accounts-ESI.AX, page-3
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ECT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.343M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $59 | 29.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 61 | 31026071 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 12757985 | 13 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| ECT (ASX) Chart |